Information Provided By: 
Fly News Breaks for July 15, 2019
PSNL
Jul 15, 2019 | 07:09 EDT
BofA Merrill Lynch analyst Derik de Bruin initiated Personalis with a Neutral rating and $27 price target. While he thinks the company will benefit from the growing need for more genomic data in immune-oncology and cancer drug development, he also believes that shares are fairly valued given the early stage of the business and limited visibility, de Bruin tells investors.
News For PSNL From the Last 2 Days
There are no results for your query PSNL
